These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Amir J; Wolf DG; Levy I Eur J Pediatr; 2010 Sep; 169(9):1061-7. PubMed ID: 20232081 [TBL] [Abstract][Full Text] [Related]
3. Ganciclovir penetrates into the cerebrospinal fluid of an infant with congenital cytomegalovirus infection. Natale F; Bizzarri B; Cardi V; Gaeta A; Villani P; Liuzzi G; De Curtis M Ital J Pediatr; 2015 Mar; 41():26. PubMed ID: 25888518 [TBL] [Abstract][Full Text] [Related]
4. Oral Valganciclovir treatment in a CMV congenital infected infant with sensorineural hearing loss (SNHL) first detected at 4 months of age. Hilgendorff A; Daiminger A; Dangel V; Kreuder J; Geidel C; Reiss I; Enders G Klin Padiatr; 2009 Dec; 221(7):448-9. PubMed ID: 20013570 [No Abstract] [Full Text] [Related]
5. Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. Müller A; Eis-Hübinger AM; Brandhorst G; Heep A; Bartmann P; Franz AR J Perinatol; 2008 Jan; 28(1):74-6. PubMed ID: 18165832 [TBL] [Abstract][Full Text] [Related]
6. Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection. Yilmaz Çiftdogan D; Vardar F J Trop Pediatr; 2011 Apr; 57(2):132-4. PubMed ID: 20576693 [TBL] [Abstract][Full Text] [Related]
7. Valganciclovir for treatment of congenital cytomegalovirus infection. Schulzke S; Bührer C Eur J Pediatr; 2006 Aug; 165(8):575-6. PubMed ID: 16534589 [No Abstract] [Full Text] [Related]
8. Assessment of patients' characteristics associated with the efficacy and safety of oral valganciclovir treatment for infants with symptomatic congenital cytomegalovirus disease. Kakei Y; Morioka I; Imai T; Itohara K; Yano I; Takahashi N; Yoshikawa T; Moriuchi H; Ito Y; Fujioka K; Oka A; J Infect Chemother; 2024 Oct; 30(10):971-977. PubMed ID: 38484931 [TBL] [Abstract][Full Text] [Related]
9. Valganciclovir versus IV ganciclovir for therapy of cytomegalovirus viremia: has victory been achieved? Avery RK Am J Transplant; 2007 Sep; 7(9):2062-3. PubMed ID: 17697259 [No Abstract] [Full Text] [Related]
10. [Prolonged treatment with valganciclovir in an infant with congenital cytomegalovirus infection]. Baquero-Artigao F; Romero Gómez MP An Pediatr (Barc); 2009 Jun; 70(6):578-81. PubMed ID: 19423406 [TBL] [Abstract][Full Text] [Related]
16. Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial. Kimberlin DW; Aban I; Peri K; Nishikawa JK; Bernatoniene J; Emonts M; Klein N; Bamford A; DeBiasi RL; Faust SN; Jones CE; McMaster P; Caserta M; Ahmed A; Sharland M; Demmler-Harrison G; Hackett S; Sánchez PJ; Shackley F; Kelly D; Dennehy PH; Storch GA; Whitley RJ; Griffiths P; J Pediatr; 2024 May; 268():113934. PubMed ID: 38309519 [TBL] [Abstract][Full Text] [Related]
17. Fulminant cytomegalovirus myocarditis in an immunocompetent host: resolution with oral valganciclovir. Padala SK; Kumar A; Padala S Tex Heart Inst J; 2014 Oct; 41(5):523-9. PubMed ID: 25425988 [TBL] [Abstract][Full Text] [Related]
18. A prospective assessment of valganciclovir for the treatment of cytomegalovirus infection and disease in transplant recipients. Humar A; Siegal D; Moussa G; Kumar D J Infect Dis; 2005 Oct; 192(7):1154-7. PubMed ID: 16136456 [TBL] [Abstract][Full Text] [Related]
19. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient. Puliyanda DP; Silverman NS; Lehman D; Vo A; Bunnapradist S; Radha RK; Toyoda M; Jordan SC Transpl Infect Dis; 2005 Jun; 7(2):71-4. PubMed ID: 16150094 [TBL] [Abstract][Full Text] [Related]
20. Symptomatic primary Cytomegalovirus infection in a HIV-positive pregnant woman. Bergin S; Ferguson W; Corcoran S; Varughese A; Byrne D; Lawless M; Eogan M; Lambert JS Int J STD AIDS; 2014 Dec; 25(14):1041-3. PubMed ID: 24648317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]